Peter Scott Chin
CIK: 0002124755
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DNLI
Denali Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Chin Peter Scott
Chin Peter Scott (SEC CIK 0002124755) files insider reports with the SEC as Chief Medical Officer of Denali Therapeutics Inc. (DNLI).
Signal8 holds 3 ownership filings by Chin Peter Scott (2 Form 3, 1 Form 4), filed between Apr 20, 2026 and Sep 9, 2026. Those filings report 1 transaction, the latest on Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chin Peter Scott's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Chin Peter Scott
- Sep 4, 2026: Open-market sale of DNLI shares (Form 4, code S).
Other insiders filing for Denali Therapeutics Inc. (DNLI)
- Thornberry Nancy, Director
- Schuth Alexander O., COFO and Secretary
- Watts Ryan J., President and CEO
- FLATLEY JAY T, Director
- Klein Peter S, Director
- Krognes Steve E., Director